[Congressional Record Volume 160, Number 85 (Tuesday, June 3, 2014)]
[Senate]
[Pages S3361-S3362]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
APPROACH TO OPIOID ADDICTION
Mr. LEAHY. Madam President, it is no secret that communities across
the country are struggling to break the cycle of addiction to powerful
opioids, including heroin. We are now seeing addiction creep into
neighborhoods and communities of all sizes, both rural and urban. My
home State of Vermont has not been spared, and it in fact has attracted
much attention for its struggles with addiction. However in many ways,
Vermont is ahead of much of the Nation when it comes to responding to
the opioid epidemic. We long ago recognized the problem, and
communities in Vermont have spent the better part of a decade coming
together to address opioid addiction.
In March I had the privilege of chairing a field hearing of the
Senate Judiciary Committee in Rutland, VT. It was the fourth time in
the past 6 years that I brought the committee to Vermont to explore
issues related to drug abuse. I heard powerful testimony discussing how
communities are responding to addiction, rethinking decades-old
approaches to prevention, treatment, and law enforcement efforts. Dr.
Harry Chen, the Vermont Department of Health commissioner and a career
emergency room physician, described what it means to recognize
[[Page S3362]]
addiction as a public health issue, expanding evidence-based prevention
and treatment services to all corners of the State.
Vermont hospitals are also rethinking best practices in light of this
epidemic. Recently, the Office of National Drug Control Policy
published an article entitled ``How a Vermont Hospital Fights the
American Opioid Epidemic.'' The article was authored by Dr. Stephen
Leffler, the chief medical officer at Fletcher Allen Health Care in
Burlington, VT. In the article, Dr. Leffler describes how Fletcher
Allen is on the leading edge of modernizing health care practices to
minimize abuse and addiction, while still providing necessary pain
management. The hospital provides clear, standardized protocols for
treating pain, defines a maximum daily dosage as guided by the latest
research, and measures patients' risk for addiction. This approach
ensures consistency in treatment and may help to stem the flow of
prescription opioid users from sliding into addiction.
The approach described in Dr. Leffler's article could potentially
serve as a model for the rest of country, and I would encourage other
States grappling with addiction to look at what Fletcher Allen is doing
in Burlington. If we are to find legislative solutions that may finally
break the cycle of opioid addiction, then surely we must carefully
consider promising, novel approaches such as this. I ask unanimous
consent that Dr. Leffler's article be printed in the Record.
There being no objection, the material was ordered to be printed in
the Record, as follows:
[From The Office of National Drug Control Policy, May 9, 2014]
How a Vermont Hospital Fights the American Opioid Epidemic
(By Dr. Stephen M. Leffler)
Over the course of my more than 20 years as an emergency
physician, I have seen thousands of patients with painful
conditions. During that same time, I have witnessed the
remarkable evolution of modern pain medication--its potential
and its pitfalls. We can now help patients manage both short-
term and long-term pain. Yet, while medications--particularly
opioids--have helped us heal patients, we have also seen
their detrimental effects, chief among them addiction.
Opioids can be very helpful for patients with conditions
such as broken bones and kidney stones, and they are also
useful after many types of surgery. They may also be used to
treat those with chronic pain--people who experience pain
carrying out normal, daily functions of life that others take
for granted. Used for short periods of time at the proper
dosage, opioids are safe medications and excellent choices
for a wide variety of acute painful conditions.
While opioids work well for pain control, they have a
number of potentially serious side effects: They can hinder
or stop breathing, cause constipation, result in drowsiness,
and act as central nervous system depressants. That's why
your doctor tells you it is not safe to drive after taking
opioids.
Another devastating side effect is addiction. The body
develops a tolerance to opioids and, after only a couple of
weeks, may require higher doses to control pain. Over time,
increasing doses of opioids may be needed to manage the same
level of pain. Patients may develop dependence--their bodies
will crave it. They will exhibit a strong desire or
compulsion to take the drug for reasons beyond simple pain
control. At this stage, if they stop taking opioids, they
will experience withdrawal. This is how opioid use can lead
to addiction and all its inherent problems for the individual
and society.
As providers, our responsibility is to carefully manage the
side effects of opioid therapy. Dependence, tolerance, and
addiction must be discussed with patients, and a careful
well-planned strategy is crucial for their extended use of
opioids.
That is exactly what we are doing at Fletcher Allen Health
Care in Burlington, Vermont. Recently, providers and pain
management experts from multiple specialties (Anesthesia,
Emergency Medicine, Family Medicine, Internal Medicine, and
Surgery) converged to standardize how we care for patients
with painful conditions and to develop best practices for our
patients.
What did we do? Here is an overview:
Systems Approach. We built standardized protocols so that
patients will get similar treatment in various settings. We
believe this standardization will help our patients and
providers. There will be clear, defined expectations and
goals for treating our patients' pain.
New Rules & Tools. We use processes and tools such as pain
agreements with patients and surveys to assess how patients
are functioning with their pain and to measure their risk for
addiction.
Defining Maximum Daily Dosage. We are one of the first
hospitals in the country to define the maximum daily dose of
opioids. Research shows that beyond certain doses, patients
experience no additional benefit. We know that very high
doses of opioids increase the risk of dangerous side effects
but offer no additional pain control.
This approach helps ensure that we are more reliable and
consistent in our approach to pain in our patients and that
our patients will know what to expect from their providers.
Gil Kerlikowske, then-Director of ONDCP, recently visited
Fletcher Allen Health Care to discuss our new approach and
tools. He lauded our systems-level strategy and our
standardized protocols. I believe that the current dialogue
in Vermont and elsewhere on how to better manage opioid abuse
will be productive and lead to changes across the country in
how these drugs are prescribed and how acute and chronic pain
is managed. Fletcher Allen Health Care is on the leading edge
of this transition and could be a model for other health
systems managing this complex issue. I hope that sharing our
practices here is the first step toward being that model.
____________________